Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for Healthcare Triangle (HCTI) over the last 5 years, with Q3 2025 value amounting to $363000.0.

  • Healthcare Triangle's Share-based Compensation rose 56000.0% to $363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $432000.0, marking a year-over-year increase of 47600.0%. This contributed to the annual value of $87000.0 for FY2024, which is 4759.04% down from last year.
  • As of Q3 2025, Healthcare Triangle's Share-based Compensation stood at $363000.0, which was up 56000.0% from $88000.0 recorded in Q1 2025.
  • In the past 5 years, Healthcare Triangle's Share-based Compensation ranged from a high of $363000.0 in Q3 2025 and a low of -$31000.0 during Q4 2023
  • Over the past 5 years, Healthcare Triangle's median Share-based Compensation value was $18000.0 (recorded in 2021), while the average stood at $56277.8.
  • In the last 5 years, Healthcare Triangle's Share-based Compensation soared by 424000.0% in 2022 and then crashed by 11428.57% in 2023.
  • Healthcare Triangle's Share-based Compensation (Quarter) stood at $5000.0 in 2021, then surged by 4240.0% to $217000.0 in 2022, then plummeted by 114.29% to -$31000.0 in 2023, then surged by 38.71% to -$19000.0 in 2024, then skyrocketed by 2010.53% to $363000.0 in 2025.
  • Its Share-based Compensation was $363000.0 in Q3 2025, compared to $88000.0 in Q1 2025 and -$19000.0 in Q4 2024.